Search alternatives:
significantly improved » significantly increased (Expand Search)
improved decrease » improved urease (Expand Search), marked decrease (Expand Search)
altered decrease » altered release (Expand Search), observed decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
Showing 121 - 140 results of 7,277 for search '(( significantly improved decrease ) OR ( significantly ((altered decrease) OR (teer decrease)) ))', query time: 0.44s Refine Results
  1. 121
    S9 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases

    S9 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases by Feng Gao (3548)

    Published 2025
    Save to List
    Saved in:
  2. 122
    S3 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases

    S3 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases by Feng Gao (3548)

    Published 2025
    Save to List
    Saved in:
  3. 123
    S7 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases

    S7 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases by Feng Gao (3548)

    Published 2025
    Save to List
    Saved in:
  4. 124
    S2 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases

    S2 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases by Feng Gao (3548)

    Published 2025
    Save to List
    Saved in:
  5. 125
    S4 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases

    S4 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases by Feng Gao (3548)

    Published 2025
    Save to List
    Saved in:
  6. 126
    S6 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases

    S6 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases by Feng Gao (3548)

    Published 2025
    Save to List
    Saved in:
  7. 127
    S5 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases

    S5 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases by Feng Gao (3548)

    Published 2025
    Save to List
    Saved in:
  8. 128
    S8 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases

    S8 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases by Feng Gao (3548)

    Published 2025
    Save to List
    Saved in:
  9. 129
    EF-24 treatment significantly reduces cell viability in leukemia cell lines.

    EF-24 treatment significantly reduces cell viability in leukemia cell lines. by Ajeet P. Singh (22298432)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 130
    EF-24 induces significant transcriptional changes in K-562 cells.

    EF-24 induces significant transcriptional changes in K-562 cells. by Ajeet P. Singh (22298432)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 131
    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  12. 132
    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  13. 133
    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  14. 134
    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  15. 135
    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  16. 136
    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  17. 137
    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  18. 138
    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  19. 139
    Phosphorylation as an Effective Tool to Improve Stability and Reduce Toxicity of Antimicrobial Peptides

    Phosphorylation as an Effective Tool to Improve Stability and Reduce Toxicity of Antimicrobial Peptides by Zufang Ba (11036420)

    Published 2024
    “…Among them, W<sub>3</sub>BipY<sub>8</sub>-P stood out as the most promising peptide, exhibiting similar antibacterial activity as its unphosphorylated analog W<sub>3</sub>BipY<sub>8</sub> but with significantly reduced hemolytic activity (19-fold decrease), cytotoxicity (3.3-fold decrease), and an extended serum half-life 6.3 times longer than W<sub>3</sub>BipY<sub>8</sub>. …”
    Save to List
    Saved in:
  20. 140
    Ni causes a decrease in membrane sterols in A549 lung epithelial cells.

    Ni causes a decrease in membrane sterols in A549 lung epithelial cells. by Amber R. Matha (19681603)

    Published 2024
    Save to List
    Saved in:

Search Tools: